echoloc
Company profile

Praxis Precision Medicines, Inc. Tech Stack

CNS precision neuroscience biopharma preparing for commercial launch

Biotechnology Research Boston, MA 201–500 employees Public Company

Praxis Precision Medicines develops genetically informed CNS therapies and appears to be moving from clinical-stage to commercial-stage operations. Director-heavy hiring across healthcare, sales and regulatory, along with NDA/MAA submission work and field readiness, points to launch preparation. In parallel, an AWS multi-account build with Pulumi, Control Tower and GuardDuty, plus Veeva PromoMats and QMS, shows GxP-grade infrastructure being put in place.

Tech Stack 39 technologies

Core StackPython SAP Salesforce Greenhouse AWS TypeScript Pulumi AWS Lambda AWS RDS DynamoDB CloudWatch Snowflake Databricks dbt Intune Veeva Microsoft Dynamics 365 AWS Amplify Bitbucket Pipelines AWS IAM Identity Center AWS Control Tower AWS KMS GuardDuty Veeva PromoMats LC-MS HPLC qPCR Veeva Vault Veeva QMS Microsoft Defender for Endpoint+9 more

What Praxis Precision Medicines, Inc. Is BuildingChallenges and projects from their job posts

◆Challenges

  • Supporting commercial launch of new products
  • Scaling regional sales capability
  • Maintaining regulatory inspection readiness
  • Speeding promotional review and reducing approval delays
  • Enterprise application support and scalability

▲Active Projects

  • NDA/MAA submissions and FDA regulatory strategy
  • Product launch and field readiness execution
  • AWS multi-account governance with Pulumi IaC
  • ERP and CRM integrations
  • Analytical method transfer and validation
  • Essential tremor advisory board engagement

Hiring Activity

Accelerating30 roles · 10 in 30d

Department

Healthcare
9
Engineering
5
Sales
3
Data
2
Manufacturing
2
Regulatory
2
Finance
1
Legal
1

Seniority

Director
11
Senior
8
Lead
4
Mid
4
Manager
2

Notable leadership hires: Combination Product Program Lead, Sales Business Director, Regional Sales Director

Companies like Praxis Precision Medicines, Inc.

100+ Biotechnology Research companies running Python and SAP

See the full list

About Praxis Precision Medicines, Inc.

Praxis Precision Medicines is a public biopharmaceutical company headquartered in Boston, MA, with 201–500 employees. It develops therapies for neurological disorders driven by an imbalance between neuronal excitation and inhibition, drawing on insights from genetic epilepsies. Its pipeline spans rare and more common brain disorders, including work in essential tremor. Discovery runs on two proprietary platforms: Cerebrum for small molecules and Solidus for antisense oligonucleotides. Hiring is concentrated in the United States.

HeadquartersBoston, MA
Company Size201–500 employees
Hiring MarketsUnited States

Frequently Asked Questions

What tech stack does Praxis Precision Medicines use?

Praxis uses AWS (Lambda, RDS, DynamoDB, Control Tower), Pulumi, TypeScript, Python, Snowflake, Databricks, dbt, Veeva Vault, PromoMats and QMS, SAP, Salesforce and Microsoft Dynamics 365.

Is Praxis Precision Medicines hiring sales roles?

Yes. Hiring is accelerating, and open leadership roles include a Sales Business Director and a Regional Sales Director, all based in the United States. This hiring lines up with commercial launch preparation.

What is Praxis Precision Medicines working on?

Current work includes FDA regulatory strategy, NDA/MAA submissions, analytical method transfer and validation, product launch execution, ERP and CRM integrations, and an AWS multi-account architecture.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

How this profile is built

Praxis Precision Medicines, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.